$CNMD
CONMED Corp Stock $cnmd

$cnmd Overview Financials Valuation SEC Filings Company Website

2011 Q4 Form 10-Q Financial Statement

#000081695611000003 Filed on November 01, 2011

Income Statement

Concept	2011 Q4	2011 Q3	2010 Q3
Revenue	$185.6M	$172.8M	$172.2M
YoY Change	0.81%	0.36%	-1.88%
Cost Of Revenue	$88.20M	$81.50M	$83.21M
YoY Change	-5.36%	-2.05%	-5.23%
Gross Profit	$96.45M	$91.31M	$88.98M
YoY Change	6.08%	2.62%	1.58%
Gross Profit Margin	51.97%	52.84%	51.68%
Selling, General & Admin	$70.30M	$68.35M	$66.09M
YoY Change	2.93%	3.42%	-2.09%
% of Gross Profit	72.89%	74.85%	74.27%
Research & Development	$7.200M	$7.021M	$7.399M
YoY Change	-11.11%	-5.11%	-3.91%
% of Gross Profit	7.46%	7.69%	8.32%
Depreciation & Amortization	$10.30M	$9.600M	$9.600M
YoY Change	7.29%	0.0%	0.0%
% of Gross Profit	10.68%	10.51%	10.79%
Operating Expenses	$77.50M	$75.37M	$73.78M
YoY Change	1.44%	2.16%	-2.02%
Operating Profit	$18.95M	$15.94M	$15.20M
YoY Change	30.5%	4.85%	23.59%
Interest Expense	-$2.100M	$1.670M	$1.749M
YoY Change	-27.59%	-4.52%	-156.42%
% of Operating Profit	-11.08%	10.48%	11.51%
Other Income/Expense, Net
YoY Change
Pretax Income	-$43.70M	$13.14M	$12.39M
YoY Change	-512.26%	6.01%	552.32%
Income Tax	-$18.60M	$4.928M	$3.636M
% Of Pretax Income		37.51%	29.34%
Net Earnings	-$25.13M	$8.211M	$8.758M
YoY Change	-460.97%	-6.25%	573.69%
Net Earnings / Revenue	-13.54%	4.75%	5.09%
Basic Earnings Per Share	-$0.90	$0.29	$0.31
Diluted Earnings Per Share	-$0.90	$0.29	$0.31
COMMON SHARES
Basic Shares Outstanding	27.92M shares	28.35M shares	28.43M shares
Diluted Shares Outstanding		28.55M shares	28.52M shares

Balance Sheet

Concept	2011 Q4	2011 Q3	2010 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.00M	$39.90M	$16.50M
YoY Change	109.68%	141.82%	16.2%
Cash & Equivalents	$26.05M	$39.88M	$16.52M
Short-Term Investments
Other Short-Term Assets	$26.60M	$24.50M	$26.00M
YoY Change	35.03%	-5.77%	-5.11%
Inventory	$168.4M	$174.8M	$183.3M
Prepaid Expenses
Receivables	$135.6M	$130.9M	$141.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$356.7M	$370.1M	$367.2M
YoY Change	1.87%	0.79%	16.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$139.2M	$139.6M	$141.8M
YoY Change	-1.21%	-1.56%	-3.14%
Goodwill	$234.8M	$295.0M
YoY Change	-20.42%
Intangibles	$195.5M	$185.4M
YoY Change	2.86%
Long-Term Investments
YoY Change
Other Assets	$9.300M	$9.100M	$7.300M
YoY Change	-2.11%	24.66%	12.31%
Total Long-Term Assets	$578.9M	$629.1M	$635.7M
YoY Change	-8.92%	-1.04%	0.05%
TOTAL ASSETS
Total Short-Term Assets	$356.7M	$370.1M	$367.2M
Total Long-Term Assets	$578.9M	$629.1M	$635.7M
Total Assets	$935.6M	$999.2M	$1.003B
YoY Change	-5.09%	-0.37%	5.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.16M	$20.76M	$28.40M
YoY Change	-2.44%	-26.9%	-8.39%
Accrued Expenses	$31.10M	$25.90M	$26.50M
YoY Change	9.51%	-2.26%	14.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$54.56M	$166.4M	$43.20M
YoY Change	-50.6%	285.15%	1957.14%
Total Short-Term Liabilities	$131.2M	$232.6M	$116.9M
YoY Change	-27.07%	98.98%	44.68%
LONG-TERM LIABILITIES
Long-Term Debt	$88.95M	$9.119M	$171.1M
YoY Change	4.43%	-94.67%	-6.45%
Other Long-Term Liabilities	$49.60M	$27.17M	$23.50M
YoY Change	76.42%	15.62%	28.42%
Total Long-Term Liabilities	$138.6M	$36.29M	$194.6M
YoY Change	22.29%	-81.35%	-3.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$131.2M	$232.6M	$116.9M
Total Long-Term Liabilities	$138.6M	$36.29M	$194.6M
Total Liabilities	$362.5M	$389.4M	$423.2M
YoY Change	-9.19%	-7.98%	11.11%
SHAREHOLDERS EQUITY
Retained Earnings	$354.4M	$379.6M
YoY Change	0.12%
Common Stock	$313.0K	$313.0K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$77.33M	$78.05M
YoY Change	8.43%
Treasury Stock Shares
Shareholders Equity	$573.1M	$609.8M	$579.7M
YoY Change
Total Liabilities & Shareholders Equity	$935.6M	$999.2M	$1.003B
YoY Change	-5.09%	-0.37%	5.4%

Cashflow Statement

Concept	2011 Q4	2011 Q3	2010 Q3
OPERATING ACTIVITIES
Net Income	-$25.13M	$8.211M	$8.758M
YoY Change	-460.97%	-6.25%	573.69%
Depreciation, Depletion And Amortization	$10.30M	$9.600M	$9.600M
YoY Change	7.29%	0.0%	0.0%
Cash From Operating Activities	$26.30M	$36.50M	$9.800M
YoY Change	14.85%	272.45%	-16.95%
INVESTING ACTIVITIES
Capital Expenditures	-$4.900M	-$4.100M	-$3.700M
YoY Change	28.95%	10.81%	-27.45%
Acquisitions
YoY Change
Other Investing Activities	-$4.100M	$0.00	$0.00
YoY Change	4000.0%		-100.0%
Cash From Investing Activities	-$9.000M	-$4.100M	-$3.800M
YoY Change	130.77%	7.89%	-26.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.80M	-15.10M	800.0K
YoY Change	36.28%	-1987.5%	-128.57%
NET CHANGE
Cash From Operating Activities	26.30M	36.50M	9.800M
Cash From Investing Activities	-9.000M	-4.100M	-3.800M
Cash From Financing Activities	-30.80M	-15.10M	800.0K
Net Change In Cash	-13.50M	17.30M	6.800M
YoY Change	275.0%	154.41%	78.95%
FREE CASH FLOW
Cash From Operating Activities	$26.30M	$36.50M	$9.800M
Capital Expenditures	-$4.900M	-$4.100M	-$3.700M
Free Cash Flow	$31.20M	$40.60M	$13.50M
YoY Change	16.85%	200.74%	-20.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	20761000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	21692000	USD
CY2011Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	130881000	USD
CY2010Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	145350000	USD
CY2011Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1661000	USD
CY2010Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	973000	USD
CY2011Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12484000	USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-15861000	USD
CY2011Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	320395000	USD
CY2010Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	319406000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	15064000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14764000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3167000	USD
CY2010Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1059000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3338000	USD
CY2011Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1131000	USD
CY2010Q4	us-gaap	Assets Assets	985773000	USD
CY2011Q3	us-gaap	Assets Assets	999192000	USD
CY2011Q3	us-gaap	Assets Current AssetsCurrent	370111000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	350192000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12417000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39883000	USD
CY2010Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16524000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10098000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	27466000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2933000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	7000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6426000	USD
CY2011Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	261018000	USD
CY2010Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	83212000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2011Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2011Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31299203	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31299203	shares
CY2011Q3	us-gaap	Common Stock Value CommonStockValue	313000	USD
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	313000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	255185000	USD
CY2011Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	81503000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	11961000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10636000	USD
CY2011Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	8719000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	8476000	USD
CY2011Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2260000	USD
CY2010Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2009000	USD
CY2010Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	106046000	USD
CY2011Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	120545000	USD
	us-gaap	Depreciation Depreciation	13700000	USD
	us-gaap	Depreciation Depreciation	12863000	USD
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2010Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.90
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2010Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.80
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	173000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-638000	USD
CY2011Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	25922000	USD
CY2010Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28411000	USD
CY2010Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-79000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2011Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2010Q4	us-gaap	Goodwill Goodwill	295068000	USD
CY2011Q3	us-gaap	Goodwill Goodwill	295009000	USD
CY2010Q3	us-gaap	Gross Profit GrossProfit	88983000	USD
	us-gaap	Gross Profit GrossProfit	274461000	USD
CY2011Q3	us-gaap	Gross Profit GrossProfit	91311000	USD
	us-gaap	Gross Profit GrossProfit	278482000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13139000	USD
CY2010Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12394000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	41381000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	35026000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11643000	USD
CY2011Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4928000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15495000	USD
CY2010Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3636000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-301000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2285000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14745000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13600000	USD
	us-gaap	Increase Decrease In Accounts Receivable From Securitization IncreaseDecreaseInAccountsReceivableFromSecuritization	0	USD
	us-gaap	Increase Decrease In Accounts Receivable From Securitization IncreaseDecreaseInAccountsReceivableFromSecuritization	29000000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	829000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-579000	USD
	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	2418000	USD
	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	-3148000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	599000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2507000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10768000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28198000	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-50823000	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	8093000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2897000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	597000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1659000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-8690000	USD
CY2010Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	190091000	USD
CY2011Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	185353000	USD
	us-gaap	Interest Expense InterestExpense	5182000	USD
CY2010Q3	us-gaap	Interest Expense InterestExpense	1749000	USD
CY2011Q3	us-gaap	Interest Expense InterestExpense	1670000	USD
	us-gaap	Interest Expense InterestExpense	5269000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	438000	USD
CY2011Q3	us-gaap	Inventory Net InventoryNet	174795000	USD
CY2010Q4	us-gaap	Inventory Net InventoryNet	172796000	USD
CY2011Q3	us-gaap	Liabilities Liabilities	389438000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	399210000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	985773000	USD
CY2011Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	999192000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	179866000	USD
CY2011Q3	us-gaap	Liabilities Current LiabilitiesCurrent	232604000	USD
CY2011Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	166383000	USD
CY2010Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	110433000	USD
CY2011Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9119000	USD
CY2010Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	85182000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CONMED Corporation (“CONMED”, the “Company”, “we” or “us”) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.  The Company’s products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring single-uses, endosurgery and endoscopic technologies.  They are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology.</font></div></div>
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7044000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35861000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16081000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12744000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15290000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	76709000	USD
CY2010Q3	us-gaap	Operating Expenses OperatingExpenses	73781000	USD
	us-gaap	Operating Expenses OperatingExpenses	230920000	USD
	us-gaap	Operating Expenses OperatingExpenses	228581000	USD
CY2011Q3	us-gaap	Operating Expenses OperatingExpenses	75371000	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	15940000	USD
CY2010Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	15202000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	49901000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	43541000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	404000	USD
	us-gaap	Proceeds From Accounts Receivable Securitization ProceedsFromAccountsReceivableSecuritization	24000000	USD
	us-gaap	Proceeds From Accounts Receivable Securitization ProceedsFromAccountsReceivableSecuritization	0	USD
CY2010Q4	us-gaap	Other Assets OtherAssets	7518000	USD
CY2011Q3	us-gaap	Other Assets OtherAssets	6874000	USD
CY2011Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17877000	USD
CY2010Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	18357000	USD
CY2011Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27170000	USD
CY2010Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28116000	USD
CY2010Q3	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	291000	USD
	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	1261000	USD
	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	792000	USD
CY2011Q3	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	22977000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15021000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	72000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	5226000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10855000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12672000	USD
CY2011Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2011Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2011Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2010Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2010Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11153000	USD
CY2011Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15833000	USD
CY2010Q3	us-gaap	Profit Loss ProfitLoss	8758000	USD
	us-gaap	Profit Loss ProfitLoss	23383000	USD
CY2011Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139585000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	140895000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5759000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	952000	USD
	us-gaap	Profit Loss ProfitLoss	25886000	USD
CY2011Q3	us-gaap	Profit Loss ProfitLoss	8211000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	1012000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	23013000	USD
CY2011Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7021000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21499000	USD
CY2010Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7399000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21522000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	354020000	USD
CY2011Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	379575000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	529646000	USD
CY2011Q3	us-gaap	Sales Revenue Net SalesRevenueNet	172814000	USD
CY2010Q3	us-gaap	Sales Revenue Net SalesRevenueNet	172195000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	539500000	USD
CY2011Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	68350000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	208137000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	206290000	USD
CY2010Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	66091000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3264000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3714000	USD
CY2011Q3	us-gaap	Stockholders Equity StockholdersEquity	609754000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	586563000	USD
CY2010Q4	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	3077377	shares
CY2011Q3	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	3389079	shares
CY2010Q4	us-gaap	Treasury Stock Value TreasuryStockValue	71315000	USD
CY2011Q3	us-gaap	Treasury Stock Value TreasuryStockValue	78045000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29073000	shares
CY2010Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28521000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28546000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28734000	shares
CY2011Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28348000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28896000	shares
CY2010Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28425000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28355000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
	dei	Document Period End Date DocumentPeriodEndDate	2011-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000816956
CY2011Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27918777	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CONMED CORP
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No

Files In Submission

Name	View Source	Status
0000816956-11-000003-index-headers.html	Edgar Link	pending
0000816956-11-000003-index.html	Edgar Link	pending
0000816956-11-000003.txt	Edgar Link	pending
0000816956-11-000003-xbrl.zip	Edgar Link	pending
cnmd-20110930.xml	Edgar Link	completed
cnmd-20110930.xsd	Edgar Link	pending
cnmd-20110930_cal.xml	Edgar Link	unprocessable
cnmd-20110930_def.xml	Edgar Link	unprocessable
cnmd-20110930_lab.xml	Edgar Link	unprocessable
cnmd-20110930_pre.xml	Edgar Link	unprocessable
cnmd9301110q.htm	Edgar Link	pending
cnmd93011ex311.htm	Edgar Link	pending
cnmd93011ex312.htm	Edgar Link	pending
cnmd93011ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNMD
CONMED Corp Stock $cnmd

2011 Q4 Form 10-Q Financial Statement

#000081695611000003 Filed on November 01, 2011

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNMD CONMED Corp Stock $cnmd

2011 Q4 Form 10-Q Financial Statement

#000081695611000003 Filed on November 01, 2011

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNMD
CONMED Corp Stock $cnmd